Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

[1]  Yoshiya Tanaka,et al.  Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis , 2018, Front. Immunol..

[2]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[3]  Guoqiang Shangguan,et al.  Biological Properties and the Role of IL-25 in Disease Pathogenesis , 2018, Journal of immunology research.

[4]  A. Barton,et al.  Rheumatoid arthritis , 2018, Nature Reviews Disease Primers.

[5]  P. Miossec,et al.  Interleukin-25 Produced by Synoviocytes Has Anti-inflammatory Effects by Acting As a Receptor Antagonist for Interleukin-17A Function , 2017, Front. Immunol..

[6]  M. Dougados,et al.  Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis , 2017, Annals of the rheumatic diseases.

[7]  Bo-Mi Kim,et al.  N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis , 2017, The Korean journal of internal medicine.

[8]  Tao Liu,et al.  IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide , 2017, Scientific Reports.

[9]  N. Ma,et al.  IL-25 attenuates rheumatoid arthritis through suppression of Th17 immune responses in an IL-13-dependent manner , 2016, Scientific Reports.

[10]  D. Voehringer,et al.  Th2 and eosinophil responses suppress inflammatory arthritis , 2016, Nature Communications.

[11]  K. Tarte,et al.  Loss of IL‐22 inhibits autoantibody formation in collagen‐induced arthritis in mice , 2016, European journal of immunology.

[12]  Juan Li,et al.  Interleukin-22 Secreted by NKp44+ Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis , 2015, Medicine.

[13]  M. V. D. van den Brink,et al.  Interleukin-22: immunobiology and pathology. , 2015, Annual review of immunology.

[14]  S. Sarkar,et al.  Endogenous IL-22 Plays a Dual Role in Arthritis: Regulation of Established Arthritis via IFN-γ Responses , 2014, PloS one.

[15]  S. Rong,et al.  Interleukin 17 Receptor A Modulates Monocyte Subsets and Macrophage Generation In Vivo , 2014, PLoS ONE.

[16]  C. Gu,et al.  IL-17 family: cytokines, receptors and signaling. , 2013, Cytokine.

[17]  Yan-Dong Zhang,et al.  IL‐22+CD4+ T cells in patients with rheumatoid arthritis , 2013, International journal of rheumatic diseases.

[18]  H. Takayanagi.  New developments in osteoimmunology , 2012, Nature Reviews Rheumatology.

[19]  S. Galdino,et al.  Increased Serum Interleukin 22 in Patients with Rheumatoid Arthritis and Correlation with Disease Activity , 2012, The Journal of Rheumatology.

[20]  Jin-Young Park,et al.  Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. , 2012, Arthritis and rheumatism.

[21]  A. Skapenko,et al.  Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[22]  Wei Li,et al.  Elevated Th22 Cells Correlated with Th17 Cells in Patients with Rheumatoid Arthritis , 2011, Journal of Clinical Immunology.

[23]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update , 2010, Annals of the rheumatic diseases.

[24]  John Wong,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.

[25]  D. Jarrossay,et al.  Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells , 2009, Nature Immunology.

[26]  K. Hiromura,et al.  Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. , 2005, Arthritis and rheumatism.

[27]  Zemin Zhang,et al.  Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.

[28]  S-Y Hwang,et al.  Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. , 2007, Rheumatology.

[29]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[30]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.